Pre-publication history
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
-
* Corresponding author: Jessica N McAlpine jessica.mcalpine@vch.ca
BMC Cancer 2009, 9:433 doi:10.1186/1471-2407-9-433
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 12 Mar 2009 | |
| Reviewer's Report | A Serrano-Olvera | 01 May 2009 | |
| Reviewer's Report | Adelaida Garcia-Velasco | 10 May 2009 | |
| Reviewer's Report | Karina Dahl Steffensen | 10 May 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 11 Jul 2009 |
| Reviewer's Report | Adelaida Garcia-Velasco | 03 Aug 2009 | |
| Reviewer's Report | Karina Dahl Steffensen | 12 Aug 2009 | |
| Resubmission - Version 3 | Manuscript | 01 Oct 2009 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 01 Oct 2009 |
| Resubmission - Version 5 | Manuscript | Author's comment | 04 Nov 2009 |
| Editorial acceptance | 18 Nov 2009 | ||
| Published | 10 Dec 2009 |